Search

Now showing items 1-10 of 243

Commentary on Almassalha Et Al., "the Greater Genomic Landscape: The Heterogeneous Evolution of Cancer"

Lynch, H. T.; Rendell, M.; Shaw, T. G.; Silberstein, P.; Ngo, B. T. (2016)

Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Kotsopoulos, J.; Huzarski, T.; Gronwald, J.; Singer, C. F.; Moller, P.; Lynch, H. T.; Armel, S.; Karlan, B.; Foulkes, W. D.; Neuhausen, S. L.; Senter, L.; Tung, N.; Weitzel, J. N.; Eisen, A.; Metcalfe, K.; Eng, C.; Pal, T.; Evans, G.; Sun, P.; Lubinski, J.; Narod, S. A.; Hereditary Breast Cancer Clinical Study Group (2016)

Mutations in the Histone Modifier PRDM6 are Associated with Isolated Nonsyndromic Patent Ductus Arteriosus

Li, N.; Subrahmanyan, L.; Smith, E.; Yu, X.; Zaidi, S.; Choi, M.; Mane, S.; Nelson-Williams, C.; Bahjati, M.; Kazemi, M.; Hashemi, M.; Fathzadeh, M.; Narayanan, A.; Tian, L.; Montazeri, F.; Mani, M.; Begleiter, M. L.; Coon, B. G.; Lynch, H. T.; Olson, E. N.; Zhao, H.; Ruland, J.; Lifton, R. P.; Mani, A. (2016)

PCCR: Pancreatic Cancer Collaborative Registry

Sherman, S.; Shats, O.; Ketcham, M. A.; Anderson, M. A.; Whitcomb, D. C.; Lynch, H. T.; Ghiorzo, P.; Rubinstein, W. S.; Sasson, A. R.; Grizzle, W. E.; Haynatzki, G.; Feng, J.; Sherman, A.; Kinarsky, L.; Brand, R. E. (2011)

Familial Atypical Multiple Mole Melanoma (FAMMM) Syndrome: History, Genetics, and Heterogeneity

Lynch, H. T.; Shaw, T. G. (2016)

Cancer Genetics

Lynch, H. T.; Boland, C. R. (Elsevier Inc., 2012)

Introduction to Special Issue of Familial Cancer

Lynch, H. T.; Snyder, C. L. (2016)

Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers?

Semple, J.; Metcalfe, K. A.; Lubinski, J.; Huzarski, T.; Gronwald, J.; Armel, S.; Lynch, H. T.; Karlan, B.; Foulkes, W.; Singer, C. F.; Neuhausen, S. L.; Eng, C.; Iqbal, J.; Narod, S. A.; Hereditary Breast Cancer Clinical Study Group (2015)

Weight gain after oophorectomy among women with a BRCA1 or BRCA2 mutation

Kotsopoulos, J.; Lubinski, J.; Neuhausen, S. L.; Gronwald, J.; Lynch, H. T.; Huzarski, T.; Demsky, R.; Foulkes, W. D.; Senter, L.; Friedman, S.; Ainsworth, P.; Sun, P.; Narod, S. A.; Hereditary Breast Cancer Clinical Study Group (2015)

Should risk-reducing surgery in women from hereditary breast ovarian cancer families be confined to removal of the fallopian tubes with ovarian conservation?

Snyder, C. L.; Casey, M. J.; Lynch, H. T. (2015)

1
2
3
4
. . .
25